Note: Ingredients listed on restricted chemical lists
EC/CAS
63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
General Information
Product name
Finasteride Tablets USP, 5 mg
1.2.1 Relevant identified uses
Finasteride Tablets USP is indicated for the treatment of benign prostatic hyperplasia (BPH) in men with an enlarged prostate
Manufacturer Name
Hetero labs limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc
Section 2
Precautionary statements
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wash thoroughly after handling. Avoid release to the environment. Collect spillage. Effects of The potential for exposure is reduced in finished pharmaceutical form. Overexposure Overexposure by ingestion may cause increased severity of adverse effects. Individuals with underlying renal disease may be at risk for acute renal failure.
Hazard statements
May be harmful if swallowed.
Health hazards
Inhalation: Not expected to be an inhalation hazard in final pharmaceutical form. Eye Contact: Not expected to be a hazard to the eye in final pharmaceutical form. Skin Contact: Not expected to be a hazard to the skin. Can cause hypersensitive reactions resulting in rash, redness, itching and inflammation. Ingestion: May be harmful if ingested. Ingestion may cause headache, nausea, diarrhea and abdominal discomfort.
